Biological characterization of glutaraldehyde-modified Parietaria judaica pollen extracts

Clinical and Experimental Allergy

Volumn 34, Issue 2, 2004, Pages 303-309

  Ibarrola, I ^a   Sanz, M L ^b   Gamboa, P M ^c   Mir, A ^d   Benahmed, D ^d   Ferrer, A ^e   Arilla, M C ^a   Martinez A ^a   Asturias, J A ^a,f  

^a Depto Investigacion y Desarrollo   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

^c HOSPITAL DE BASURTO   (Spain)

^d UNIVERSITY OF VALENCIA   (Spain)

^e HOSPITAL VEGA BAJA   (Spain)

^f R and D Department   (Spain)

Author keywords

Allergoids; Basophil activation; Chemical modification; Chromatography; Histamine release test; Lymphocyte proliferation; Parietaria judaica; Skin prick test

Indexed keywords

AMINO ACID; ANTIALLERGIC AGENT; GLUTARALDEHYDE; IMMUNOGLOBULIN E; PARIETARIA JUDAICA EXTRACT; PLANT EXTRACT; POLLEN ANTIGEN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ALLERGENICITY; ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CELL STIMULATION; CHEMICAL ANALYSIS; CHEMICAL MODIFICATION; CONTROLLED STUDY; DIAFILTRATION; FEMALE; HUMAN; IMMUNOASSAY; IMMUNOGENICITY; IMMUNOTHERAPY; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PARIETARIA; PARIETARIA JUDAICA; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERIZATION; PRICK TEST; PRIORITY JOURNAL; PROTEIN PURIFICATION;

ADOLESCENT; ADULT; ALLERGENS; ANIMALS; DESENSITIZATION, IMMUNOLOGIC; FEMALE; FILTRATION; GLUTARAL; HUMANS; HYPERSENSITIVITY; IMMUNOLOGIC TESTS; MALE; MIDDLE AGED; PARIETARIA; PLANT EXTRACTS; POLLEN; RABBITS; SKIN TESTS;

EID: 1542285233     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2004.01859.x     Document Type: Article

References (30)

1. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 1998; 351:1225-32.
2. Durham SR, Walker SM, Varga EM et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Eng J Med 1999; 341:468-75.
3. Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 1998; 53:1-42.
4. Grammer LC, Shaughnessy MA, Patterson R. Standardization of modified allergens using polymerized ragweed as a model system. Clin Rev Allergy 1987; 5:107-16.
5. Gieni RS, Yang X, Kelso A, Hayglass KT. Limiting dilution analysis of CD T-cell cytokine production in mice administered native vs. polymerized ovalbumin: directed induction of T-helper type 1-like activation. Immunology 1996; 87:119-26.
6. Patterson R, Suszko IM, Pruzansky JJ, Zeiss CR, Metzger WJ, Roberts M. Polymerization of mixtures of grass allergens. J Allergy Clin Immunol 1977; 59:314-9.
7. Gieni RS, Yang X, Kelso A, HayGlass KT. Limiting dilution analysis of CD4 T-cell cytokine production in mice administered native vs. polymerized ovalbumin: directed induction of T-helper type-1-like activation. Immunology 1996; 87:119-26.
8. Ariano R, Kroon AM, Augeri G, Canonica GW, Passalacqua G. Long-term treatment with allergoid immunotherapy with Parietaria. Clinical and immunologic effects in a randomized, controlled trial. Allergy 1999; 54:313-9.
9. Tari MG, Mancino M, Ghezzi E, Frank E, Cromwell O. Immunotherapy with an alum-adsorbed Parietaria-pollen allergoid: a 2-year, double-blind, placebo-controlled study. Allergy 1997; 52:65-74.
10. Bousquet J, Hejjaoui A, Soussana M, Michel FB. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. IV. Comparison of the safety and efficacy of two dosages of a high-molecular-weight allergoid. J Allergy Clin Immunol 1990; 85:490-7.
11. Pastorello EA, Pravettoni V, Incorvaia C et al. Clinical and immunological effects of immunotherapy with alum-absorbed grass allergoid in grass-pollen-induced hay fever. Allergy 1992; 47:281-90.
12. Hendrix SG, Patterson R, Zeiss CR et al. A multi-institutional trial of polymerized whole ragweed for immunotherapy of ragweed allergy. J Allergy Clin Immunol 1980; 66:486-94.
13. Colombo P, Duro G, Costa MA et al. An update on allergens. Parietaria pollen allergens. Allergy 1998; 53:917-21.
14. García Ortega P, Martínez J, Martínez A, Palacios R, Belmonté J, Richart C. Mercurialis annua pollen: a new source of allergic sensitization and respiratory disease. J Allergy Clin Immunol 1992; 89:987-93.
15. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-54.
16. 4. Nature 1970; 277:680-5.
17. Willis TW, Tu AT. Purification and biochemical characterization of atroxase, a nonhemorrhagic fibrionolytic protease from western diamondbach rattlesnake venom. Biochemistry 1988; 27:4769-77.
18. Ceska M, Eriksson R, Varga J. Radioimmunosorbent assay of allergens. J Allergy Clin Immunol 1972; 49:1-9.
19. Sanz ML, Sánchez G, Gamboa Vila L, Uasuf C, Chazot M. Allergen-induced basophil activation: CD63 cell expression detected by flow cytometry in patients allergic to Dermatophagoides pteronyssinus and Lolium perenne. Clin Exp Allergy 2001; 31:1007-13.
20. Siraganian RP. Histamine secretion from mast cells and basophils. Trends Pharmacol Sci 1983; 4:432-7.
21. Resano A, Prieto I, Sanz ML, Oehling A. Reliability of histamine release test in dust mite allergy: influence of the sensitisation degree. J Invest Allergol Clin Immunol 1995; 5:289-93.
22. Akdis CA, Blaser K. Regulation of specific immune responses by chemical and structural modifications of allergens. Int Arch Allergy Immunol 2000; 121:261-9.
23. Hopkins M, Lees BG, Richardson DG, Woroniecki SR, Wheeler AW. Standardisation of glutaraldehyde-modified tyrosine-adsorbed tree pollen vaccines containing the Th1-including adjuvant, monophosphoyl lipid A (MPL). Allergol Immunopathol 2001; 29:245-54.
24. Patterson R, Suszko IM, Grammer LC, Shaughnessy MA. Polymerization of individual species of grass pollen allergens. J Allergy Clin Immunol 1983; 72:129-33.
25. Wihl JA, Pilstrom L, Maasch HJ. Studies on allergen and allergoid preparations from purified timothy (Phleum pratense) pollen extracts. III. Comparative investigations by skin prick tests and nasal provocation tests. Int Arch Allergy Appl Immunol 1985; 76:162-7.
26. Cirkovic T, Jankulovic MG, Prisic S et al. The influence of a residual group in low-molecular-weight allergoids of Artemisia vulgaris pollen on their allergenicity, IgE- and IgG-binding properties. Allergy 2002; 57:1013-20.
27. Gewurz A, Grammer LC, Shaughnessy MA, Patterson R. Soluble copolymer of wasp venom with human albumin for venom immunotherapy. J Allergy Clin Immunol 1986; 77:520-3.
28. Dormann D, Ebner C, Jarman ER, Montermann E, Kraft D, Reske-Kunz AB. Responses of human birch pollen allergen-reactive T cells to chemically modified allergens (allergoids). Clin Exp Allergy 1998; 28:1374-83.
29. Kahlert H, Stüwe H-Th, Cromwell O, Fiebig H. Reactivity of T cells with grass pollen allergen extract and allergoid. Int Arch Allergy Immunol 1999; 120:146-57.
30. Kahlert H, Griebenow EG, Stüwe H-Th, Cromwell O, Fiebig H. T cell reactivity with allergoid: influence of the type of APC. J Immunol 2000; 165:1807-15.